Wikidata

(Q61918311)

English

Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
HEART (English)
0 references
title
A Multicenter, Phase 4, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Recombinant Alpha-Galactosidase A (Agalsidase Beta, FABRAZYME) in Heterozygous Females for Fabry Disease (English)
0 references
country
France
0 references
start time
June 2005
0 references
number of participants
34
0 references
minimum age
15 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61918311&oldid=2149376780"